英文摘要 |
Objective: Transverse myelitis (TM) is one of the neurological manifestations of systemic lupus erythematosus (SLE). It can bring about long-term neurological sequelae and even mortalities. However, only a few studies have described its characteristics. This study provided data in Taiwanese Han SLE patients with TM. Methods: We recruited 12 SLE patients with 17 episodes of transverse myelitis from July 2002 to June 2012 and reviewed their medical records. Demographic data, clinical characteristics, laboratory findings and radiographic features were obtained. Severity of TM was expressed in Expanded Disability Status Scale (EDSS) scoring. Results: The median age of the 12 patients (two males and ten females) was 34 years. Among the 17 TM episodes, there was a greater than 3-point change in SLEDAI score in 64.7%, indicating a lupus flare. Most of patients had either elevated cerebrospinal fluid IgG index or protein. Involvement of more than 4 segments in spinal MRI was observed in most episodes (83.3%) of TM. Antiphospholipid antibodies were detected in only 8.3% of our patients and no case of antiphospholipid antibody syndrome was documented. More severe disease was associated with increased white blood cell count in cerebrospinal fluid and thrombocytopenia, manifested concomitant with or before the episode of TM. There was only modest improvement after treatment 6 months later in terms of EDSS scores. Conclusion: Among the Taiwanese Han population, TM is similar to that in Caucasians in many aspects. Generalized lupus flare is often present. Antiphospholipid antibodies may play a minor role in TM pathogenesis in Taiwanese SLE patients, in contrast to Caucasians with SLE-related TM. |